Skip to main content
. Author manuscript; available in PMC: 2019 Sep 30.
Published in final edited form as: Psychiatry Res Neuroimaging. 2018 Jul 29;279:22–30. doi: 10.1016/j.pscychresns.2018.07.003

Table 2.

Correlations between PRESS and three MEGA-PRESS measures of glx

Controls (n=25) Patients (n=17) All (n=42)
r (r2) with
PRESS
CoV
(%)
r (r2) with
PRESS
CoV
(%)
r (r2) with
PRESS
CoV
(%)
PRESS --- 11.9 --- 9.8 --- 10.9
MP-Off 0.88 (0.77) 9.2 0.76 (0.58) 8.9 0.84 (.70) 9.0
MP-Diff 0.16 (0.03)** 10.1 0.44 (0.20)a 8.8 0.26 (.07)** 9.7
MP-Diff-PI 0.36 (0.13)** 10.2 0.49 (0.24)a 11.0 0.40 (.16)** 11.0

Abbreviations as in Table 1; MP-Diff-PI = MEGA-PRESS difference spectra with glx/creatine quantified by peak integration, all others are glx/creatine from LCModel fits. Note that since peak integration cannot estimate glutamate separately from glutamine, peak integration values are only shown in Table 2.

**

lower than PRESS vs MP-Off correlation, p < .0001

*

lower than PRESS vs MP-Off correlation, p < .05

a

NS, p ≤ .14